Little Green Pharma Ltd. (AU:LGP)
ASX:LGP
Want to see AU:LGP full AI Analyst Report?
LGP Stock Chart & Stats
AU$0.10
<AU$0.01(1.67%)
At close: 4:00 PM EST
AU$0.10
<AU$0.01(1.67%)
Day’s Range― - ―
52-Week RangeAU$0.07 - AU$0.15
Previous CloseN/A
Volume21.69K
Average Volume (3M)234.87K
Market Cap
AU$57.40M
Enterprise ValueAU$28.30M
Total Cash (Recent Filing)AU$1.42M
Total Debt (Recent Filing)AU$4.69M
Price to Earnings (P/E)2.6
Beta0.84
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding819,978,700
10 Day Avg. Volume223,605
30 Day Avg. Volume234,865
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)0.36
Price to Sales (P/S)0.70
P/FCF Ratio-37.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetA low debt load versus substantial equity provides durable financial flexibility, lowering refinancing and solvency risk. This conservatively levered position supports continued investment in cultivation and regulatory compliance, helping the business withstand industry volatility over months.
Multi-year Revenue Scale-upSustained top-line expansion over several years indicates successful market penetration and product adoption across regulated channels. Scale benefits support negotiated distribution, manufacturing leverage and potential margin improvement if revenue stabilizes, strengthening long-term commercial position.
Improving Cash Generation TrendA move to near-breakeven operating cash flow signals operational progress and lower cash burn versus prior years. If sustained, this trend reduces dependence on external funding and enables reinvestment in production or market expansion, improving resilience over the next several months.
Bears Say
Recent Revenue DeclineA measurable YoY revenue decline erodes scale economics and may indicate weakening demand, pricing pressure, or mix shifts. Over a 2-6 month horizon this threatens margin sustainability and could constrain ability to absorb fixed cultivation and manufacturing costs if the trend continues.
Ongoing Losses And Negative FCFContinued net losses and negative free cash flow mean operations do not yet self-fund growth, raising the prospect of further external capital needs. Persistent deficits can limit strategic investments, increase dilution risk, and pressure management to cut costs or shift strategy in coming months.
Inconsistent Profitability & ReturnsVolatile earnings and uneven returns reduce predictability of future performance and complicate capital allocation. This structural inconsistency can hinder investor confidence and makes planning for stable margin expansion and reinvestment more difficult over the medium term.
Little Green Pharma Ltd. News
LGP FAQ
What was Little Green Pharma Ltd.’s price range in the past 12 months?
Little Green Pharma Ltd. lowest share price was AU$0.07 and its highest was AU$0.14 in the past 12 months.
What is Little Green Pharma Ltd.’s market cap?
Little Green Pharma Ltd.’s market cap is AU$57.40M.
When is Little Green Pharma Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Little Green Pharma Ltd.’s earnings last quarter?
Currently, no data Available
Is Little Green Pharma Ltd. overvalued?
According to Wall Street analysts Little Green Pharma Ltd.’s price is currently Overvalued.
Does Little Green Pharma Ltd. pay dividends?
Little Green Pharma Ltd. does not currently pay dividends.
What is Little Green Pharma Ltd.’s EPS estimate?
Little Green Pharma Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Little Green Pharma Ltd. have?
Little Green Pharma Ltd. has 819,978,700 shares outstanding.
What happened to Little Green Pharma Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Little Green Pharma Ltd.?
Currently, no hedge funds are holding shares in AU:LGP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Little Green Pharma Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
21.73%
12-Months-Change
Fundamentals
Return on Equity
10.34%
Trailing 12-Months
Asset Growth
-2.46%
Trailing 12-Months
Company Description
Little Green Pharma Ltd.
Little Green Pharma Ltd, established in 2016 and based in West Perth, Australia, specializes in the worldwide cultivation, manufacturing, and distribution of medicinal cannabis products. Its extensive product range encompasses cannabis flower medicines, various cannabis extracts, tinctures, and active pharmaceutical ingredients (APIs), serving markets both within Australia and internationally.
Technical Analysis
Cann Group
―
Epsilon Healthcare Limited
―
―
IDT Australia Limited
―
Cronos Australia Ltd.
―
Options Prices
Currently, No data available
---